Abstract: The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2”). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.
Type:
Grant
Filed:
November 30, 2022
Date of Patent:
February 27, 2024
Assignees:
AMGEN INC., VIGIL NEUROSCIENCE, INC.
Inventors:
Lara C. Czabaniuk, Timothy Hopper, Jonathan B. Houze, Jane Panteleev, Gwenaella Rescourio, Vincent Santora, Haoxuan Wang, Ryan D. White, Alice R. Wong, Yongwei Wu, Maxence Bos, John Mancuso, Ivan Franzoni
Abstract: A system for retrieving information related to a topic of interest, comprising: (a) a finder for finding a location of a computerized source of information, the information being divided into at least one message, such that the source of information is a located source of information, the finder being a self-operated software program; (b) a source repository for storing the location of the located source of information; (c) a sampler for sampling the located source of information by retrieving the at least one message from the located source of information, such that the at least one message is a retrieved message, the sampler being a self-operated software program; (d) a matcher for determining a matching score for the retrieved message, the matcher being a self-operated software program; and (e) a message repository for storing the retrieved message and the matching score.